These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25540379)

  • 1. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
    Wiens ME; Smith JG
    J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Defensin HD5 Inhibits Human Papillomavirus 16 Infection via Capsid Stabilization and Redirection to the Lysosome.
    Wiens ME; Smith JG
    mBio; 2017 Jan; 8(1):. PubMed ID: 28119475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
    Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
    J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
    Cruz L; Biryukov J; Conway MJ; Meyers C
    Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Defensin HD5 Stabilizes
    Gulati NM; Miyagi M; Wiens ME; Smith JG; Stewart PL
    Pathog Immun; 2019; 4(2):196-234. PubMed ID: 31583330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
    Day PM; Thompson CD; Lowy DR; Schiller JT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
    Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
    mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
    Cerqueira C; Samperio Ventayol P; Vogeley C; Schelhaas M
    J Virol; 2015 Jul; 89(14):7038-52. PubMed ID: 25926655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.
    Day PM; Thompson CD; Schowalter RM; Lowy DR; Schiller JT
    J Virol; 2013 Apr; 87(7):3862-70. PubMed ID: 23345514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
    Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.
    Lipovsky A; Erden A; Kanaya E; Zhang W; Crite M; Bradfield C; MacMicking J; DiMaio D; Schoggins JW; Iwasaki A
    J Gen Virol; 2017 Nov; 98(11):2821-2836. PubMed ID: 29058661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.
    Schäfer G; Graham LM; Lang DM; Blumenthal MJ; Bergant Marušič M; Katz AA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
    Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
    PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy.
    Vragniau C; Hübner JM; Beidler P; Gil S; Saydaminova K; Lu ZZ; Yumul R; Wang H; Richter M; Sova P; Drescher C; Fender P; Lieber A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
    Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
    J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering.
    Skeate JG; Segerink WH; Garcia MD; Fernandez DJ; Prins R; Lühen KP; Voss FO; Da Silva DM; Kast WM
    Front Immunol; 2020; 11():561843. PubMed ID: 33154746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry.
    Zhang P; Moreno R; Lambert PF; DiMaio D
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6121-6128. PubMed ID: 32123072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
    Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
    Becker M; Greune L; Schmidt MA; Schelhaas M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
    DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
    J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.